HighTower Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Buy
56,744
+23,336
+70% +$604K ﹤0.01% 1950
2025
Q4
$849K Hold
33,408
﹤0.01% 2242
2025
Q3
$539K Buy
33,408
+16
+0% +$259 ﹤0.01% 2559
2025
Q2
$534K Buy
33,392
+119
+0.4% +$1.8K ﹤0.01% 2464
2025
Q1
$569K Buy
33,273
+238
+0.7% +$4.98K ﹤0.01% 2351
2024
Q4
$818K Sell
33,035
-189
-0.6% -$5.36K ﹤0.01% 2114
2024
Q3
$947K Buy
33,224
+7,259
+28% +$214K ﹤0.01% 1957
2024
Q2
$685K Sell
25,965
-1,379
-5% -$39.2K ﹤0.01% 2097
2024
Q1
$884K Buy
27,344
+21
+0.1% +$766 ﹤0.01% 1879
2023
Q4
$1.15M Buy
27,323
+3,000
+12% +$110K ﹤0.01% 1773
2023
Q3
$933K Buy
24,323
+76
+0.3% +$1.72K ﹤0.01% 1816
2023
Q2
$460K Hold
24,247
﹤0.01% 2260
2023
Q1
$376K Hold
24,247
﹤0.01% 2296
2022
Q4
$431K Hold
24,247
﹤0.01% 2226
2022
Q3
$135K Hold
24,247
﹤0.01% 2704
2022
Q2
$94K Hold
24,247
﹤0.01% 2799
2022
Q1
$134K Hold
24,247
﹤0.01% 2928
2021
Q4
$206K Buy
+24,247
New +$200K ﹤0.01% 2754
2021
Q1
Sell
-4,600
Closed -$209K 3153
2020
Q4
$209K Buy
+4,600
New +$213K ﹤0.01% 2174

Other funds holding IMVT